- February 16, 2015Read more
The former head of Johnson & Johnson's ($JNJ) initiative to develop stratified drugs for Alzheimer's disease is trying to crowdfund the development of computer simulations of brain disorders. Magali Haas is seeking $299,900 for the project, which builds on a multiple sclerosis prediction model created by her nonprofit, Orion Bionetworks.
- February 11, 2015Read more
It began with a phone call. The guidance counselor from our local high school, calling to say my oldest daughter, Madison, was being transported to a local emergency room. As a parent of 4 children, having a child rushed to an emergency room is old hat, but this wasn’t an “I can handle it” typical situation. Madison was being sent to a psychiatric emergency room for immediate evaluation. To say I was stunned is a complete understatement.
- February 1, 2015Read more
The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.
Orion CEO Magali Haas Featured in Partnering for Cures panel: Unlocking the Mysteries of the Human BrainNovember 25, 2014Read more
What if we started diagnosing brain disorders based on physiological measures as opposed to the behavioral measures that are currently in use now? This is the provocative question that kicked off the five-person panel discussion at the sixth annual Partnering for Cures, moderated by Kafui Dzirasa of Duke University Medical Center.
- November 6, 2014Read more
Nature Neuroscience presents a Focus on Big Data in their November Issue